300705: Hunan Jiudian Pharmaceutical Co., Ltd. - Summary | Jitta

Hunan Jiudian Pharmaceutical Co., Ltd.

CHN:300705

Price
CN¥12.85
Loss Chance
41.8%
6.10JITTA SCORE
53.79%Under Jitta Line
Jitta Ranking
274 / 487
2,600 / 5,259
Grow your money with Jitta Ranking. See details.
HISTORICAL JITTA SCORE
Jitta Factors
Growth Opportunity (47)
Recent Business Performance (22)
Financial Strength (92)
Return to Shareholders (57)
Competitive Advantage (58)
Jitta Signs
Revenue and EarningConsistent High Growth in the past 5 years
Operating MarginConsistent
Debt LevelLow Long Term Debt
Dividend PayoutIncreasing Every Year
SG&A to SalesDecreasing
Recent Business PerformanceEarning decline 55.59% in the last quarter (yoy)
Cash Conversion CycleMore than 120 days
Key Stats
Jitta Score
Jitta Line
6.10
53.79%
4.42
> 1,000%
4.24
> 1,000%
Pharmaceuticals
6.36
2.64%
5.47
25.22%
7.76
43.10%
COMPANY DESCRIPTION
Hunan Jiudian Pharmaceutical Co., Ltd. researches, develops, produces, and sells pharmaceutical products in China and internationally. Its products portfolio includes Pantoprazole Sodium Enteric-coated, Ferrous Succinate, Rosuvastatin Calcium, Ebastine, and Rabeprazole Sodium Enteric-coated Tablets; and Acetylcysteine Granules, Potassium Sodium Hydrogen Citrate Granules, Loxoprofen Sodium Gel Patch, and Ketoprofen gel patch. The company also offers drugs for analgesic, cardio-cerebrovascular, anti-infection, digestive and urinary system, and breathing and anti-allergy. In addition, it provides CMO/CDMO services. The company was founded in 2001 and is based in Changsha, China.